Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Phathom Pharmaceuticals Inc (PHAT)

Phathom Pharmaceuticals Inc (PHAT)
6.94 -0.01 (-0.14%) 01/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 6.94 unch (unch) 01/10/25
Quote Overview for Fri, Jan 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.73
Day High
7.11
Open 6.91
Previous Close 6.95 6.95
Volume 995,700 995,700
Avg Vol 1,018,605 1,018,605
Stochastic %K 9.22% 9.22%
Weighted Alpha -2.52 -2.52
5-Day Change -0.39 (-5.32%) -0.39 (-5.32%)
52-Week Range 6.07 - 19.71 6.07 - 19.71
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 474,536
  • Shares Outstanding, K 68,377
  • Annual Sales, $ 680 K
  • Annual Income, $ -201,590 K
  • EBIT $ -288 M
  • EBITDA $ -286 M
  • 60-Month Beta 0.56
  • Price/Sales 15.78
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 94.58% ( -71.53%)
  • Historical Volatility 61.85%
  • IV Percentile 31%
  • IV Rank 37.02%
  • IV High 189.87% on 01/12/24
  • IV Low 38.56% on 10/07/24
  • Put/Call Vol Ratio 0.11
  • Today's Volume 234
  • Volume Avg (30-Day) 308
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 8,570
  • Open Int (30-Day) 10,270

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.05
  • Number of Estimates 1
  • High Estimate -1.05
  • Low Estimate -1.05
  • Prior Year -0.80
  • Growth Rate Est. (year over year) -31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.73 +3.12%
on 01/10/25
Period Open: 8.93
9.10 -23.69%
on 12/11/24
-1.99 (-22.28%)
since 12/10/24
3-Month
6.73 +3.12%
on 01/10/25
Period Open: 15.71
19.50 -64.41%
on 11/04/24
-8.77 (-55.82%)
since 10/10/24
52-Week
6.07 +14.43%
on 02/13/24
Period Open: 8.09
19.71 -64.79%
on 09/19/24
-1.15 (-14.22%)
since 01/10/24

Most Recent Stories

More News
Insider Purchase: Director at $PHAT (PHAT) Buys 12,500 Shares

FRANK KARBE, a director at $PHAT ($PHAT), bought 12,500 shares of the company on 12-13-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals Submits Citizen Petition to Correct NCE Exclusivity Date for VOQUEZNA Tablets

Phathom Pharmaceuticals submitted a Citizen Petition to correct VOQUEZNA's NCE exclusivity expiration date to May 3, 2032.Quiver AI SummaryPhathom Pharmaceuticals has submitted a Citizen Petition to the...

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

PHAT : 6.94 (-0.14%)
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

PHAT : 6.94 (-0.14%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Phantom Pharmaceuticals, Inc. (NASDAQ: PHAT) concerning possible breaches...

PHAT : 6.94 (-0.14%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Phantom Pharmaceuticals, Inc. (NASDAQ: PHAT) concerning possible breaches...

PHAT : 6.94 (-0.14%)
PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws

/PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Phathom...

PHAT : 6.94 (-0.14%)

Business Summary

Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel treatments for gastrointestinal diseases. The company's product pipeline consists of vonoprazan, which are in clinical stage. Phathom Pharmaceuticals Inc. is based in Buffalo...

See More

Key Turning Points

3rd Resistance Point 7.50
2nd Resistance Point 7.31
1st Resistance Point 7.12
Last Price 6.94
1st Support Level 6.74
2nd Support Level 6.55
3rd Support Level 6.36

See More

52-Week High 19.71
Fibonacci 61.8% 14.50
Fibonacci 50% 12.89
Fibonacci 38.2% 11.28
Last Price 6.94
52-Week Low 6.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Trading Volume: The most powerful technical indicator in the world